April 14th 2025
The FDA has approved the new indication for Zoetis' Simparica Trio
April 3rd 2025
Data on US states with the highest infection rates for heartworm, Lyme disease, anaplasmosis, and ehrlichiosis is presented.
April 1st 2025
Communications expert Wendy S. Myers provides scripts for confident client conversations
March 26th 2025
Zoetis has launched its’ 0.5 mL dose for intranasal Vanguard B
March 25th 2025
The innovation also has the potential to detect other diseases in livestock, in addition to detecting up to 200 types of cancers
dvm360® product report: Inventory system, plus cattle vaccines, and more
Here's our regular rundown of new and notable veterinary products
No evidence of cancer found in dog after novel vaccine therapy
Developed by a Yale researcher, this cancer treatment can offer a new solution for canines
User-friendly nozzles and shields for cattle intranasal vaccinations
This new product from Merck Animal Health offers an efficient and accurate vaccine administration
Preventing canine parvovirus infection
The virus was one of the ‘hot topics’ in infectious diseases discussed during a session at the 2024 Veterinary Meeting & Expo
Preventing mushroom toxicosis in our companion animals
Identifying signs, understanding mycology, and educating clients help keep pets safe
The quest for a tick-free summer
Protecting patients, clients, and the environment from ticks
Preventing Lyme disease
The threat of Lyme Borreliosis is real, but with the appropriate preventative action, we can avoid it
USDA provides conditional license for the Canine Parvovirus Monoclonal Antibody
This brand-new treatment from Elanco is the first and only approved therapeutic solution proven to treat canine parvovirus
Protecting dogs against seasonal infection
Spring is a good time to ensure pets are vaccinated against common diseases
Porcine parvovirus vaccine demonstrates promise in clinical study
The platform technology, in which specific antigens are expressed by genetically modified yeast cells, was developed by the research and development team of Germany-based serYmun Yeast GmbH.
Risk, revolution, and preventive medicine
How preventive medicine has evolved over time